A microglia replacement approach demonstrates that brain macrophages with patient mutations from Aicardi–Goutières syndrome, a genetic, brain predominant interferonopathy, are sufficient to drive ...

ProMIS Neurosciences, Inc. (Nasdaq: PMN), a clinical-stage biotechnology company developing next-generation therapies for ...

A 58-year-old woman was admitted to the hospital 3 weeks after lumbar surgery because of diplopia and fever. Left leg pain and a rash had preceded the fever and diplopia. A diagnosis was made.

ProMIS Neurosciences, Inc. (Nasdaq: PMN), a clinical-stage biotechnology company developing next-generation therapies for Alzheimer's disease ...

Deep brain stimulation (DBS) improves motor symptoms of Parkinson's disease by modulating a specific brain network that is mainly active in the fast beta frequency range (20 to 35 Hz). This conclusion ...

Scientists have found a key brain network that’s disrupted by Parkinson’s disease, according to a study published today in ...

BACKGROUND: The disruption of the blood–brain barrier (BBB) is a central pathogenic event in many central nervous system disorders. However, the mechanisms regulating BBB function remain incompletely ...

An international research team has uncovered new insights into healthy brain aging. The researchers found that aging leads to ...

A common parasite long thought to lie dormant is actually much more active and complex. Researchers found that Toxoplasma ...

BISC is an ultra-thin neural implant that creates a high-bandwidth wireless link between the brain and computers. Its tiny single-chip design packs tens of thousands of electrodes and supports ...

Modern neuroscience and the computational modeling of the activities of vast, integrated neural networks provide fruitful ...

Parkinson's disease does more than cause tremors and trouble walking. It can also affect sleep, smell, digestion and even thinking. NPR's Jon Hamilton reports on new research suggesting that's because ...